Discerning strategies to upregulate or stabilize DOC2B protein levels in skeletal muscle could provide avenues to prevent and/or reverse skeletal muscle insulin resistance and halt progression to pre-T2D and T2D. This evidence concerns the gene DOC2B and Insulin resistance.